MedTrace Logo

MUSCLE - Nordic Walking in MUltiple SCLErosis

NCT05385731 · Status: UNKNOWN · Phase: NA · Type: INTERVENTIONAL · Enrollment: 60

Last updated 2022-05-23

No results posted yet for this study

Summary

The aim of the study is to analyze the effects of Nordic Walking and free walking in the clinical-functional, postural balance, motor control, muscular echographic quality, and gait analysis (pendulum gait mechanism), in people with Multiple Sclerosis.

Conditions

  • Multiple Sclerosis, Chronic Progressive
  • Multiple Sclerosis
  • Multiple Sclerosis, Primary Progressive
  • Multiple Sclerosis, Secondary Progressive

Interventions

OTHER

Nordic Walking (NWG)

24 sessions will be held twice a week, with each session taking an average of 60 minutes.

OTHER

Free Walking (FWG)

24 sessions will be held twice a week, with each session taking an average of 60 minutes.

OTHER

Health Education (HEG)

The control group will receive orientation and carry out the "Health Education" program and will have a duration of 3 months.

Sponsors & Collaborators

  • Aline Nogueira Haas

    collaborator UNKNOWN

  • Flávia Gomes Martinez

    collaborator UNKNOWN

  • Leonardo A. Peyré-Tartaruga

    lead OTHER

Study Design

Allocation
RANDOMIZED
Purpose
TREATMENT
Masking
TRIPLE
Model
PARALLEL

Eligibility

Min Age
20 Years
Max Age
75 Years
Sex
ALL
Healthy Volunteers
No

Timeline & Regulatory

Start
2022-08-02
Primary Completion
2022-12-30
Completion
2024-12-30

Countries

  • Brazil

Study Locations

More Related Trials

Entities

Diseases

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT05385731 on ClinicalTrials.gov